Supply of Morphine Sulfate Injection (Pharmaceutical Product)

The contract entails the procurement and delivery of two packages of Morphine Sulfate Injection, a critical pharmaceutical product, under strict compliance with Defense Logistics Agency standards for handling, packaging, and labeling. All shipments must adhere to FOB destination terms, ensuring the supplier assumes responsibility for the product until it reaches the designated delivery point, with full accountability for condition and compliance throughout transit. The product is classified under NAICS code 325412, confirming its designation as a pharmaceutical manufacturing activity, and is awarded as a subcontract under the Department of Defense. Issued by the Defense Logistics Agency, the contract is tied to the award reference SPE2DP26F7903 and is publicly accessible via the DIBBS portal. Although the solicitation number and specific point of contact are not provided, the posting date of July 21, 2026, indicates it is a forward-looking procurement. The place of performance and office address details remain unspecified, implying logistical arrangements are managed under broader DLA frameworks. The procurement supports military medical readiness and requires full adherence to federal pharmaceutical and defense supply chain protocols without flexibility in compliance requirements.